Latest Breaking News On - Chemoresistant ovarian - Page 1 : comparemela.com

Investegate |Midatech Pharma PLC Announcements | Midatech Pharma PLC: R&D Programme Focused on Leptomeningeal Disease

Investegate announcements from Midatech Pharma PLC, R&D Programme Focused on Leptomeningeal Disease

United kingdomUnited statesCity ofDmitry zamoryakhinMatthew chandler rob patrickTim metcalfe grahamEdison group us investor relationsAdvisory limited financialMidatech pharmaStrand hanson limited nominated adviserExchange commissionLondon stock exchangePreclinical rd programme focusedChemoresistant ovarianIntj molHanson limited

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines

United kingdomUnited statesCity ofMatthew chandler rob patrickMidatech pharma plcviewDmitry zamoryakhinTim metcalfe grahamEdison group us investor relationsStrand hanson limited nominated adviserLondon stock exchangeMidatech pharmaAdvisory limited financialExchange commissionChemoresistant ovarianIntj molHanson limited

Midatech Pharma (MTP) Announces R&D Programme Focused on Leptomeningeal Disease

Midatech Pharma (MTP) Announces R&D Programme Focused on Leptomeningeal Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofUnited statesTim metcalfe grahamMatthew chandler rob patrickDmitry zamoryakhinExchange commissionStrand hanson limited nominated adviserLondon stock exchangeAdvisory limited financialEdison group us investor relationsMidatech pharmaWall streetChemoresistant ovarianIntj molHanson limited